The Computational Analysis Facility provides access to and expertise in high-performance computers and software for biological research in the institution. The facility, located on the thirteenth floor of the Houston Main Building, provides computer network access through Ethernet connections to all components of M.D. Anderson. Initially, the facility focused on computer support for the analysis of sequence data, including supplying the requisite programs for the manipulation of such data and database-searching technology. This support is being extended to providing software and expertise for molecular modeling of sequence data. While these types of analyses are necessary for conducting research in molecular biology today, few laboratories can afford to devote a person to the full- time activities required to remain current in this yield. Moreover, even few laboratories are able to support a person to find, install, and evaluate programs in the public domain that might be critical to one phase of research. Finally, few individual laboratories can afford the software licensing fees and the special computers required for analyses such as molecular modeling. Moreover, assistance with packages that are used only occasionally in a laboratory can be better obtained by a central resource facility like the CAF. At a lower level, the facility acts as a general ombudsman for general questions on computing and computers. Traditionally, the facility has measured its use by the number of central processing unit (CPU) hours used by all users. From December, 1993 to June, 1997, individuals in 21 Anderson departments used 3,866 CPU hours. In addition, the Facility teaches a graduate course on sequence analysis with a specific format making it easy for researchers to attend only the parts relevant to their research. This and other CAF activities are advertised through a newsletter and a World Wide Web page. In the future, the Facility will extend its computer support into related areas in which specialized software running on high-performance computers may be of use to a large number of users, such as three-dimensional analysis of confocal microscopy images obtained in the Automated Cytometry and Cell Sorter Laboratory/Confocal Microscopy and Image Analysis Facility. The policies of the Computational Analysis Facility are overseen by a committee comprised of Drs. de Crombrugghe, Marsha Frazier (Gastrointestinal Oncology and Digestive Diseases), and R. Allen White (biomathematics).

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
3P30CA016672-25S1
Application #
6347273
Study Section
Project Start
2000-08-30
Project End
2001-06-30
Budget Start
Budget End
Support Year
25
Fiscal Year
2000
Total Cost
$254,104
Indirect Cost
Name
University of Texas MD Anderson Cancer Center
Department
Type
DUNS #
001910777
City
Houston
State
TX
Country
United States
Zip Code
77030
Staffas, Anna; Burgos da Silva, Marina; Slingerland, Ann E et al. (2018) Nutritional Support from the Intestinal Microbiota Improves Hematopoietic Reconstitution after Bone Marrow Transplantation in Mice. Cell Host Microbe 23:447-457.e4
Boddu, Prajwal; Borthakur, Gautam; Koneru, Mythili et al. (2018) Initial Report of a Phase I Study of LY2510924, Idarubicin, and Cytarabine in Relapsed/Refractory Acute Myeloid Leukemia. Front Oncol 8:369
Takahashi, Nobuaki; Chen, Hsing-Yu; Harris, Isaac S et al. (2018) Cancer Cells Co-opt the Neuronal Redox-Sensing Channel TRPA1 to Promote Oxidative-Stress Tolerance. Cancer Cell 33:985-1003.e7
Garg, Rachana; Blando, Jorge M; Perez, Carlos J et al. (2018) COX-2 mediates pro-tumorigenic effects of PKC? in prostate cancer. Oncogene 37:4735-4749
Flinn, Ian W; O'Brien, Susan; Kahl, Brad et al. (2018) Duvelisib, a novel oral dual inhibitor of PI3K-?,?, is clinically active in advanced hematologic malignancies. Blood 131:877-887
Subbiah, Ishwaria M; Tang, Chad; Rao, Arvind et al. (2018) Older adults in phase I clinical trials: a comparative analysis of participation and clinical benefit rate among older adults versus middle age and AYA patients on phase I clinical trials with VEGF/VEGFR inhibitors. Oncotarget 9:28842-28848
Daver, Naval; Boddu, Prajwal; Garcia-Manero, Guillermo et al. (2018) Hypomethylating agents in combination with immune checkpoint inhibitors in acute myeloid leukemia and myelodysplastic syndromes. Leukemia 32:1094-1105
Bailey, Matthew H; Tokheim, Collin; Porta-Pardo, Eduard et al. (2018) Comprehensive Characterization of Cancer Driver Genes and Mutations. Cell 173:371-385.e18
Ohri, Nisha; Sittig, Mark P; Tsai, Chiaojung Jillian et al. (2018) Trends and variations in postmastectomy radiation therapy for breast cancer in patients with 1 to 3 positive lymph nodes: A National Cancer Data Base analysis. Cancer 124:482-490
Cao, Qizhen; Yan, Xinrui; Chen, Kai et al. (2018) Macrophages as a potential tumor-microenvironment target for noninvasive imaging of early response to anticancer therapy. Biomaterials 152:63-76

Showing the most recent 10 out of 12418 publications